journal article·2023-03Open access

Melittin‐Carrying Nanoparticle Suppress T Cell‐Driven Immunity in a Murine Allergic Dermatitis Model

Zheng Liu, Zhan Fan, Jinxin Liu, Jialu Wang, Mengli Xu, Xinlin Li, Yilun Xu, Yafang Lu, Chenlu Han, Zhihong Zhang

Advanced Science· Volume 10· Issue 7

Abstract

Abstract Allergic contact dermatitis (ACD) and atopic dermatitis (AD) are the most common human skin disorders. Although corticosteroids have been widely used to treat ACD and AD, the side effects of corticosteroids encourage researchers to explore new immunoregulatory treatments. Here, an immunomodulatory approach based on lipid nanoparticles carrying α‐helical configurational melittin (α‐melittin‐NP) is developed to overcome T cell‐mediated inflammatory reactions in an oxazolone (OXA)‐induced contact hypersensitivity mouse model and OXA‐induced AD‐like mouse model. Intradermal injection of low‐dose α‐melittin‐NPs prevents the skin damage caused by melittin administration alone and efficiently targeted lymph nodes. Importantly, melittin and α‐melittin‐NPs restrain RelB activity in dendritic cells (DCs) and further suppresses dendritic cell activation and maturation in lymph nodes. Furthermore, low‐dose α‐melittin‐NPs leads to relief of antigen recognition‐induced effector T cell arrest in the dermis and inhibited allergen‐specific T cell proliferation and activation. Significantly, this approach successfully controls Th1‐type cytokine release in the ACD model and restricts Th2‐type cytokine and IgE release in the AD‐like model. Overall, intradermal delivery of low‐dose α‐melittin‐NPs efficiently elicits immunosuppression against T cell‐mediated immune reactions, providing a promising therapeutic strategy for treating skin disorders not restricted to the lesion region.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Dermatology and Skin Diseases · Healthcare and Venom Research · Bee Products Chemical Analysis

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Britton Chance Center and MOE Key Laboratory for Biomedical Photonics Wuhan National Laboratory for Optoelectronics Huazhong University of Science and Technology Wuhan Hubei 430074 China

School of Biomedical Engineering Hainan University Haikou Hainan 570228 China

Funding

National Natural Science Foundation of China · Fundamental Research Funds for the Central Universities · China Postdoctoral Science Foundation

References (47)

Show source-provided references
1. 10.1136/bmj.i329910.1136/bmj.i3299 ↗
2. 10.1038/s41572-018-0001-z10.1038/s41572-018-0001-z ↗
3. 10.1586/1744666X.2016.112015910.1586/1744666X.2016.1120159 ↗
4. 10.1080/09546634.2017.137007410.1080/09546634.2017.1370074 ↗
5. 10.2174/13892001079119630010.2174/138920010791196300 ↗
6. 10.1136/bjo.82.6.70410.1136/bjo.82.6.704 ↗
7. 10.1016/j.jaad.2005.04.03010.1016/j.jaad.2005.04.030 ↗
8. 10.1038/s41577-018-0084-510.1038/s41577-018-0084-5 ↗
9. 10.1038/s41423-019-0291-410.1038/s41423-019-0291-4 ↗
10. 10.1038/nri315010.1038/nri3150 ↗
11. 10.1038/sj.jid.570101110.1038/sj.jid.5701011 ↗
12. 10.1038/s41565-020-00810-210.1038/s41565-020-00810-2 ↗
13. 10.1021/nn405033r10.1021/nn405033r ↗
14. 10.1016/j.biomaterials.2014.06.04410.1016/j.biomaterials.2014.06.044 ↗
15. 10.1126/scitranslmed.300756310.1126/scitranslmed.3007563 ↗
16. 10.1073/pnas.140868611110.1073/pnas.1408686111 ↗
17. 10.1093/intimm/dxh18810.1093/intimm/dxh188 ↗
18. 10.1186/s12906-016-1019-y10.1186/s12906-016-1019-y ↗
19. 10.1111/bph.1448710.1111/bph.14487 ↗
20. 10.1016/j.ejphar.2014.06.05810.1016/j.ejphar.2014.06.058 ↗
21. 10.1016/j.intimp.2015.02.02110.1016/j.intimp.2015.02.021 ↗
22. 10.1046/j.1365-2222.2001.01171.x10.1046/j.1365-2222.2001.01171.x ↗
23. 10.1007/BF0199324510.1007/BF01993245 ↗
24. 10.1016/S0041-0101(03)00045-X10.1016/S0041-0101(03)00045-X ↗
25. 10.1002/anie.20090311210.1002/anie.200903112 ↗
26. 10.1021/nn400683s10.1021/nn400683s ↗
27. 10.1016/j.compmedimag.2011.09.00210.1016/j.compmedimag.2011.09.002 ↗
28. 10.1038/ni.299210.1038/ni.2992 ↗
29. 10.1038/jid.2010.38610.1038/jid.2010.386 ↗
30. 10.1038/nprot.2011.43810.1038/nprot.2011.438 ↗
31. 10.1016/j.jid.2018.01.01810.1016/j.jid.2018.01.018 ↗
32. 10.1142/S179354582050007810.1142/S1793545820500078 ↗
33. 10.1007/s11427-018-9470-910.1007/s11427-018-9470-9 ↗
34. 10.1038/nri237910.1038/nri2379 ↗
35. 10.1146/annurev.immunol.25.022106.14171810.1146/annurev.immunol.25.022106.141718 ↗
36. 10.3892/etm.2016.298910.3892/etm.2016.2989 ↗
37. 10.1046/j.1365-3083.2001.00998.x10.1046/j.1365-3083.2001.00998.x ↗
38. 10.1038/cmi.2016.3910.1038/cmi.2016.39 ↗
39. 10.1038/ni.244610.1038/ni.2446 ↗
40. 10.1038/jid.2014.7510.1038/jid.2014.75 ↗
41. 10.4049/jimmunol.178.9.548010.4049/jimmunol.178.9.5480 ↗
42. 10.1016/j.biomaterials.2016.05.00810.1016/j.biomaterials.2016.05.008 ↗
43. 10.1038/366421a010.1038/366421a0 ↗
44. 10.1172/JCI11404710.1172/JCI114047 ↗
45. 10.1002/eji.183026123310.1002/eji.1830261233 ↗
46. 10.1038/s41467-020-14906-910.1038/s41467-020-14906-9 ↗
47. 10.1158/2159-8290.CD-18-139310.1158/2159-8290.CD-18-1393 ↗